Glioma targeted therapy: insight into future of molecular approaches
Gliomas are the common type of brain tumors originating from glial cells. Epidemiologically,
gliomas occur among all ages, more often seen in adults, which males are more susceptible …
gliomas occur among all ages, more often seen in adults, which males are more susceptible …
Targeting TGFβ signal transduction for cancer therapy
S Liu, J Ren, P Ten Dijke - Signal transduction and targeted therapy, 2021 - nature.com
Transforming growth factor-β (TGFβ) family members are structurally and functionally related
cytokines that have diverse effects on the regulation of cell fate during embryonic …
cytokines that have diverse effects on the regulation of cell fate during embryonic …
Mechanisms of chemotherapy resistance in triple-negative breast cancer—how we can rise to the challenge
M Nedeljković, A Damjanović - Cells, 2019 - mdpi.com
Triple-negative (TNBC) is the most lethal subtype of breast cancer owing to high
heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the …
heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the …
Brain immunology and immunotherapy in brain tumours
Gliomas, the most common malignant primary brain tumours, remain universally lethal. Yet,
seminal discoveries in the past 5 years have clarified the anatomy, genetics and function of …
seminal discoveries in the past 5 years have clarified the anatomy, genetics and function of …
Molecular targeted therapy of glioblastoma
E Le Rhun, M Preusser, P Roth, DA Reardon… - Cancer treatment …, 2019 - Elsevier
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
Next generation of immune checkpoint therapy in cancer: new developments and challenges
JA Marin-Acevedo, B Dholaria, AE Soyano… - Journal of hematology & …, 2018 - Springer
Immune checkpoints consist of inhibitory and stimulatory pathways that maintain self-
tolerance and assist with immune response. In cancer, immune checkpoint pathways are …
tolerance and assist with immune response. In cancer, immune checkpoint pathways are …
[PDF][PDF] Targeting cancer stemness in the clinic: from hype to hope
Tumors are composed of non-homogeneous cell populations exhibiting varying degrees of
genetic and functional heterogeneity. Cancer stem cells (CSCs) are capable of sustaining …
genetic and functional heterogeneity. Cancer stem cells (CSCs) are capable of sustaining …
Targeting TGF-β signaling in cancer
S Colak, P Ten Dijke - Trends in cancer, 2017 - cell.com
The transforming growth factor (TGF)-β signaling pathway is deregulated in many diseases,
including cancer. In healthy cells and early-stage cancer cells, this pathway has tumor …
including cancer. In healthy cells and early-stage cancer cells, this pathway has tumor …
[HTML][HTML] Clinical development of therapies targeting TGFβ: current knowledge and future perspectives
D Ciardiello, E Elez, J Tabernero, J Seoane - Annals of Oncology, 2020 - Elsevier
Transforming growth factor beta (TGFβ) is a pleiotropic cytokine that plays a key role in both
physiologic and pathologic conditions, including cancer. Importantly, TGFβ can exhibit both …
physiologic and pathologic conditions, including cancer. Importantly, TGFβ can exhibit both …
Molecular mechanisms of treatment resistance in glioblastoma
A Ou, WKA Yung, N Majd - International journal of molecular sciences, 2020 - mdpi.com
Glioblastoma is the most common malignant primary brain tumor in adults and is almost
invariably fatal. Despite our growing understanding of the various mechanisms underlying …
invariably fatal. Despite our growing understanding of the various mechanisms underlying …